
Following the recent election, the so-called 'Trump trade' has concluded a two-year period of gains for investors, prompting advice to protect existing wealth. In the pharmaceutical sector, dealmaking has emerged as a notable area of collaboration between China and the West, with industry observers closely monitoring potential changes under the incoming Trump administration. In the broader market, stocks experienced a rally, with the NASDAQ and S&P 500 reaching new record highs, while the Dow Jones and Russell 2000 indices faced declines, reflecting mixed performance across the indexes.

The so-called Trump trade capped two years of gains for investors. Now it’s time to buckle up and protect the wealth you have. https://t.co/FgX7LfVOnh https://t.co/DqrpTnn21Y
Pharmaceutical dealmaking has become a rare bright spot for collaboration between China and the West. Industry watchers are holding their breath to see how the incoming Trump administration changes that https://t.co/iavU12lII8
#GlobalMarketUpdate Most #stocks jumped today while the indexes split. #NASDAQ and #SP500 closed with new record highs; #DowJones slipped to the red, as did #Russell2000, but it’s knocking on the ceiling. The rally has continued on expectations of President-elect Trump’s… https://t.co/ML6JwJ06e7